Validation of an AI‑ECG tool to detect left ventricular systolic dysfunction in community-based patients with suspected heart failure and elevated NT‑proBNP.

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: HFrEF therapy: beyond current standards Heart Failure with Reduced Ejection Fraction (HFrEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology